ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+1.18%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$254M
AUM Growth
+$254M
(+7.8%)
Cap. Flow
+$18.5M
Cap. Flow
% of AUM
7.29%
Top 10 Holdings %
Top 10 Hldgs %
43.68%
Holding
89
New
20
Increased
18
Reduced
11
Closed
35
Top Buys
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$9.64M |
| 2 |
Takeda Pharmaceutical
TAK
|
$8.77M |
| 3 |
SIEN
Sientra, Inc.
SIEN
|
$7.38M |
| 4 |
Humana
HUM
|
$7.38M |
| 5 |
Encompass Health
EHC
|
$7.27M |
Top Sells
| 1 |
Icon
ICLR
|
$13.8M |
| 2 |
Gilead Sciences
GILD
|
$10.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
$9.3M |
| 4 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$6M |
| 5 |
Evolent Health
EVH
|
$5.27M |
Sector Composition
| 1 | Healthcare | 77.04% |
| 2 | Technology | 6.14% |
| 3 | Industrials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Evolent Health
EVH
$1.11B
| – | – |
-418,728
| Closed | -$5.27M |
|
77
Elevance Health
ELV
$72.4B
| – | – |
-9,084
| Closed | -$2.61M |
|
78
Dynavax Technologies
DVAX
$1.19B
| – | – |
-41,288
| Closed | -$302K |
|
79
CVS Health
CVS
$93B
| – | – |
-11,036
| Closed | -$595K |
|
80
Centene
CNC
$14.8B
| – | – |
-54,995
| Closed | -$2.92M |
|
81
Bausch Health
BHC
$2.72B
| – | – |
-104,344
| Closed | -$2.58M |
|
82
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-52,268
| Closed | -$744K |
|
83
AnaptysBio
ANAB
$630M
| – | – |
-6,082
| Closed | -$444K |
|
84
Aldeyra Therapeutics
ALDX
$350M
| – | – |
-23,576
| Closed | -$213K |
|
85
Abbott
ABT
$230B
| – | – |
-23,966
| Closed | -$1.92M |
|
86
Agilent Technologies
A
$35.5B
| – | – |
-12,583
| Closed | -$1.01M |
|